PAHC vs XRAY · P/E 13, rev $1.52B vs rev $1.78B
Phibro Animal Health Corporation (PAHC) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Phibro Animal Health Corporation (PAHC) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported PAHC revenue for 2026-06-30 was $1.52B. Net income was $99.7M. Revenue was up 17.1% from 2025-06-30 to 2026-06-30. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
Latest reported XRAY revenue for 2026-06-30 was $1.78B. Net income was $27.0M. XRAY currently screens at market cap $2.01B.
PAHC currently screens at market cap $1.25B and trailing P/E 13.2. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the PAHC and XRAY stock pages for the full models.
Not investment advice.